The World Bank Working for a World Free of Poverty Microdata Library
  • Data Catalog
  • About
  • Collections
  • Citations
  • Terms of use
  • Login
    Login
    Home / Central Data Catalog / SIEF / PHL_2014_I3QUIPIE-BL_V01_M / variable [F5]
sief

Impact of Incentives and Information on Quality and Utilization in Primary Care 2014, Baseline Survey

Philippines, 2014
Get Microdata
Reference ID
PHL_2014_I3QUIPIE-BL_v01_M
DOI
https://doi.org/10.48529/yv2x-rq07
Producer(s)
Damien B.C.M da Walque, Taejong Kim, John Basa
Collection(s)
The Strategic Impact Evaluation Fund (SIEF) Impact Evaluation Surveys
Metadata
Documentation in PDF DDI/XML JSON
Created on
Feb 03, 2017
Last modified
Jul 10, 2019
Page views
157552
Downloads
27169
  • Study Description
  • Data Description
  • Documentation
  • Get Microdata
  • Data files
  • A01_noID
  • B02_noID
  • C03_noID
  • D04_noID
  • E05_noID
  • F06_noID
  • G07_noID
  • G7X_noID
  • H08_noID
  • I09_noID

Others [spontaneous] (C7_4_Spon)

Data file: E05_noID

Overview

Valid: 49
Invalid: 0
Type: Discrete
Start: 2517
End: 2587
Width: 71
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
Acosbos 1
2%
Aspirin 1
2%
Biguanides 1
2%
Citagliphine with metformine DPP4 inhibitors 1
2%
Citagliptines 1
2%
Combination 1
2%
Combination 1, Insulin 1
2%
Combination drugs 1
2%
Combinations 1
2%
Depends on result of FBS (more than 200 insulin) 1
2%
Dimicron 1
2%
Glimeparide 2
4.1%
Glimeperide 4
8.2%
Glimeperide Tab. (2,3,4 mg) 1
2%
Glimeperide, Comnbinations of the drugs 1
2%
Glimeperide; Insulin 1
2%
Glimepiride 1
2%
Glimiperide, Piobletazone or combinations 1
2%
Glimiperides 1
2%
Glimperide, Pioglitazole 1
2%
Glipermeperide 1
2%
Glipicide 1
2%
Glipizide 1
2%
Gliptines 1
2%
Gribecozide 1
2%
Herbal-Ampalaya 1
2%
Insulin 11
22.4%
Insulin if FBS result is too high (200); Glimeperide 1
2%
Insulin if too high 1
2%
Insulin, Dioglitazone, Vildagliptin, Alipizide, Aimeperide, Sitaglipten 1
2%
Linagliphine 1
2%
Metformin & Glilazide 1
2%
Pyoglitazine 1
2%
Simvastatine, Aspirin, Ace Inhibitors 1
2%
Sulforylureas 1
2%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
The World Bank Working for a World Free of Poverty
  • IBRD IDA IFC MIGA ICSID

© The World Bank Group, All Rights Reserved.

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.